BeStock  

Bioventus BVS

US equityMarket cap rank #3408Medical Devices
$9.88 −$0.07 (-0.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.88 0.00%
Open$9.85
Prev close$9.95
Day range$9.81 – $10.17
Volume612.4K
Market cap$676.53M
P/E (TTM)12.2
Dividend yield–

Earnings

Average move on report day±14.0%last 16 reports
Closed higher12 of 1675% of the time
Best reaction+29.2%
Worst reaction-16.8%

Stock move on the day after each report

+5.5%2023/Q4+28.0%2024/Q1+29.2%2024/Q2-16.3%2024/Q3+23.3%2024/Q4-11.8%2025/Q1+18.7%2025/Q2+15.1%2025/Q3+7.4%2025/Q4+2.2%2026/Q1+13.7%2026/Q2-16.8%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q32 Nov 2026After Market±23.8%-16.77%Within range
2026/Q25 Aug 2026Pre Market±18.7%+13.71%Within range
2026/Q16 May 2026Pre Market±20.4%+2.25%Within range
2025/Q45 Mar 2026Pre Market±24.2%+7.44%Within range
2025/Q34 Nov 2025Pre Market±28.2%+15.09%Within range
2025/Q26 Aug 2025Pre Market±21.3%+18.73%Within range
2025/Q16 May 2025Pre Market±21.9%-11.81%Within range
2024/Q411 Mar 2025Pre Market±17.8%+23.29%Bigger than priced
2024/Q35 Nov 2024Pre Market±22.0%-16.27%Within range
2024/Q26 Aug 2024Pre Market–+29.23%–
2024/Q17 May 2024Pre Market±15.0%+28.00%Bigger than priced
2023/Q412 Mar 2024Pre Market±12.8%+5.46%Within range
2023/Q37 Nov 2023Pre Market±23.6%+0.42%Within range
2023/Q28 Aug 2023Pre Market±31.2%+14.12%Within range
2023/Q116 May 2023After Market±120.8%+9.17%Within range
2022/Q431 Mar 2023Pre Market±99.2%-11.57%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Pain Treatments$71.34M 50.1%
  • Surgical Solutions$50.52M 35.5%
  • Restorative Therapies$20.59M 14.5%

Latest reported quarter: Q3, ended Sep 2026

Revenue$142.44M+2.7% YoY
Operating profit$9.70M-13.8% YoY
Net profit$6.86M+71.2% YoY
Diluted EPS$0.08+60.0% YoY
Free cash flow$20.32M-31.4% YoY
Operating cash flow$20.66M

Revenue, last 8 quarters

$153.6MDec '24$123.9MMar '25$147.7MJun '25$138.7MSep '25$157.9MDec '25$132.1MMar '26$153.2MJun '26$142.4MSep '26

Net profit, last 8 quarters

$-603.0KDec '24$-3.3MMar '25$9.3MJun '25$4.0MSep '25$17.3MDec '25$3.9MMar '26$36.2MJun '26$6.9MSep '26

Profitability & balance sheet

Gross margin68.7%
Operating margin10.1%
Net margin9.8%
Return on equity28.2%
Return on assets8.3%
Return on invested capital14.1%
Current ratio1.68
Liabilities / assets56.7%
Cash & investments$30.71M
Total debt$229.83M
Net cash (debt)-$199.12M
Free cash flow / sales14.5%

Discussion

No comments yet — be the first to weigh in on BVS.

Sign in to join the discussion.

Scroll to Top